Boryung Pharm (003850) — Cash Flow Quality Index
Boryung Pharm (003850) has a Cash Flow Quality Index of 1.44x as of September 2025. Operating cash flow of ₩48.95 Billion exceeds net income of ₩34.00 Billion, indicating high earnings quality where cash backs reported profits. Explore Boryung Pharm operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Boryung Pharm Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Boryung Pharm across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Boryung Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Boryung Pharm (2009–2024)
Year-by-year earnings quality comparison for Boryung Pharm. For live market cap and the full company financial profile, see 003850 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.11x | ₩80.56 Billion | ₩72.77 Billion | ▲ +5.4% |
| 2023 | 1.05x | ₩42.22 Billion | ₩40.20 Billion | ▲ +54.5% |
| 2022 | 0.68x | ₩27.81 Billion | ₩40.92 Billion | ▼ -51.4% |
| 2021 | 1.40x | ₩60.17 Billion | ₩43.04 Billion | ▼ -16.1% |
| 2020 | 1.67x | ₩44.74 Billion | ₩26.86 Billion | ▲ +14.2% |
| 2019 | 1.46x | ₩47.00 Billion | ₩32.22 Billion | ▼ -23.9% |
| 2018 | 1.92x | ₩38.91 Billion | ₩20.31 Billion | ▲ +541.4% |
| 2017 | -0.43x | ₩-24.61 Billion | ₩56.70 Billion | ▼ -126.0% |
| 2016 | 1.67x | ₩9.36 Billion | ₩5.61 Billion | ▼ -14.7% |
| 2012 | 1.95x | ₩18.38 Billion | ₩9.40 Billion | ▲ +31.5% |
| 2011 | 1.49x | ₩9.19 Billion | ₩6.18 Billion | ▼ -11.5% |
| 2010 | 1.68x | ₩24.12 Billion | ₩14.35 Billion | ▲ +142.4% |
| 2009 | 0.69x | ₩3.59 Billion | ₩5.18 Billion | — |